Welcome to the ATTD 2023 Interactive Program
Session Time
16:40 - 18:00
Session Description
Ahead of the Curve: Inpatient Use of Dexcom G6 and Automated Insulin Delivery Systems - Industry Symposium Supported by Dexcom Session Description: The emergence of diabetes technology in the hospital holds the potential to revolutionize glycemic management and change the standard of care. In this session, you’ll learn how these technologies are fueling the possibility in different patient populations and hospital settings. Our esteemed panel will discuss continuation of Dexcom RT-CGM upon hospital admission and an associated accuracy analysis in the pediatric population, preservation of intensive care unit capacity by using Dexcom G6 in a stepdown unit for patients admitted with diabetic ketoacidosis, feasibility of an automated insulin delivery system in patients with type 1 or type 2 diabetes in a medical-surgical unit, and perioperative use of fully closed-loop insulin delivery.
Accuracy of Dexcom G6 in Hospitalized Children (ID 1116)
Lecture Time
16:40 - 16:55
Session Time
16:40 - 18:00
Preserving ICU Capacity During the COVID-19 Pandemic: Using Remote Glucose Monitoring in Patients with Diabetic Ketoacidosis Treated in the Stepdown Unit (ID 1117)
Lecture Time
16:55 - 17:15
Session Time
16:40 - 18:00
Automated Insulin Delivery for Inpatients with Dysglycemia (AIDING) Feasibility Study (ID 1118)
Lecture Time
17:15 - 17:30
Session Time
16:40 - 18:00
Fully Closed-Loop Insulin Delivery for Perioperative Glucose Control (ID 1119)
Lecture Time
17:30 - 17:50
Session Time
16:40 - 18:00
Q&A (ID 1120)
Lecture Time
17:50 - 18:00
Session Time
16:40 - 18:00